| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |